Page last updated: 2024-09-05

dabigatran and Cerebral Infarction, Middle Cerebral Artery

dabigatran has been researched along with Cerebral Infarction, Middle Cerebral Artery in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's9 (90.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Hu, MH; Wang, V; Wu, BC1
Alvarez Bravo, G; Carvalho Monteiro, G; López Zuazo, I; Orts Castro, E1
Aoki, J; Kanamaru, T; Kimura, K; Matsumoto, N; Mishina, M; Nishiyama, Y; Nito, C; Okubo, S; Sakamoto, Y; Sekine, T; Shimoyama, T; Suda, S; Suzuki, K1
Hayama, M; Inoue, H; Mio, T; Wada, H1
Bolbrinker, J; Douros, A; Ebinger, M; Kreutz, R; Schlemm, L1
Berrouschot, J; Eschenfelder, CC; Hogh, T; Stoll, A1
Braemswig, TB; Eschenfelder, CC; Nolte, CH1
Chiu, L; Chong, CA1
Conners, JJ; Lee, VH; Prabhakaran, S1
El Khoury, R; Lopez, G; Misra, V; Sangha, N1

Other Studies

10 other study(ies) available for dabigatran and Cerebral Infarction, Middle Cerebral Artery

ArticleYear
The resolution of carotid arterial thrombus by oral anticoagulation after IV thrombolysis for chemotherapy-induced stroke: A case report.
    Medicine, 2020, Aug-28, Volume: 99, Issue:35

    Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Antithrombins; Carotid Artery Thrombosis; Carotid Artery, Internal; Dabigatran; Female; Humans; Infarction, Middle Cerebral Artery; Magnetic Resonance Angiography; Middle Aged; Plaque, Atherosclerotic; Sigmoid Neoplasms; Thrombolytic Therapy; Tissue Plasminogen Activator

2020
Intravenous Fibrinolysis in Ischemic Stroke of Large Vessel after Reversing Effect of Dabigatran with Idarucizumab.
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2017, Volume: 26, Issue:9

    Topics: Administration, Intravenous; Aged; Antibodies, Monoclonal, Humanized; Anticoagulants; Blood Coagulation; Dabigatran; Diffusion Magnetic Resonance Imaging; Female; Fibrinolytic Agents; Humans; Infarction, Middle Cerebral Artery; Thrombolytic Therapy; Tissue Plasminogen Activator; Tomography, X-Ray Computed; Treatment Outcome

2017
Prior Direct Oral Anticoagulant Therapy is Related to Small Infarct Volume and No Major Artery Occlusion in Patients With Stroke and Non-Valvular Atrial Fibrillation.
    Journal of the American Heart Association, 2018, 09-04, Volume: 7, Issue:17

    Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Cerebral Angiography; Dabigatran; Diffusion Magnetic Resonance Imaging; Female; Humans; Infarction, Middle Cerebral Artery; International Normalized Ratio; Logistic Models; Magnetic Resonance Angiography; Male; Multivariate Analysis; Prothrombin Time; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Severity of Illness Index; Stroke; Thiazoles; Warfarin

2018
Massive haemoptysis following dabigatran administration in a patient with bronchiectasis.
    BMJ case reports, 2014, Feb-19, Volume: 2014

    Topics: Aged; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Bronchial Arteries; Bronchiectasis; Dabigatran; Embolization, Therapeutic; Female; Hemoptysis; Humans; Infarction, Middle Cerebral Artery; Radiography

2014
Insufficient anticoagulation with dabigatran in a patient with short bowel syndrome.
    Thrombosis and haemostasis, 2014, Volume: 112, Issue:2

    Topics: Administration, Oral; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; Biological Availability; Blood Coagulation; Dabigatran; Drug Monitoring; Drug Substitution; Factor Xa Inhibitors; Female; Humans; Infarction, Middle Cerebral Artery; Intestinal Absorption; Morpholines; Predictive Value of Tests; Pyridines; Risk Factors; Rivaroxaban; Short Bowel Syndrome; Thiophenes; Treatment Outcome

2014
Intravenous Thrombolysis With Recombinant Tissue-Type Plasminogen Activator in a Stroke Patient Receiving Dabigatran Anticoagulant After Antagonization With Idarucizumab.
    Stroke, 2016, Volume: 47, Issue:7

    Topics: Aged; Antibodies, Monoclonal, Humanized; Antidotes; Atrial Fibrillation; Brain Ischemia; Dabigatran; Diabetes Mellitus, Type 2; Humans; Hypertension; Infarction, Middle Cerebral Artery; Male; Paresis; Recombinant Proteins; Recovery of Function; Severity of Illness Index; Thrombolytic Therapy; Thrombophilia; Tissue Plasminogen Activator

2016
Emergency LP in a patient receiving dabigatran after antagonization with idarucizumab.
    The American journal of emergency medicine, 2017, Volume: 35, Issue:4

    Topics: Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antidotes; Antithrombins; Aphasia; Atrial Fibrillation; Carotid Stenosis; Dabigatran; Emergencies; Emergency Service, Hospital; Endarterectomy, Carotid; Hemorrhage; Humans; Infarction, Middle Cerebral Artery; Magnetic Resonance Imaging; Male; Spinal Puncture; Tomography, X-Ray Computed; Ultrasonography

2017
Dabigatran and acute stroke thrombolysis.
    Cerebrovascular diseases (Basel, Switzerland), 2010, Volume: 30, Issue:2

    Topics: Acute Disease; Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; Contraindications; Dabigatran; Drug Administration Schedule; Female; Humans; Infarction, Middle Cerebral Artery; Pyridines; Thrombolytic Therapy

2010
Intravenous thrombolysis in a stroke patient taking dabigatran.
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2012, Volume: 21, Issue:8

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Coagulation; Cerebral Angiography; Dabigatran; Fibrinolytic Agents; Humans; Infarction, Middle Cerebral Artery; International Normalized Ratio; Male; Middle Aged; Partial Thromboplastin Time; Platelet Count; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Tomography, X-Ray Computed; Treatment Outcome

2012
Acute ischemic stroke treated with intravenous tissue plasminogen activator in a patient taking dabigatran with radiographic evidence of recanalization.
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2012, Volume: 21, Issue:8

    Topics: Angiography, Digital Subtraction; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cerebral Angiography; Dabigatran; Fibrinolytic Agents; Humans; Infarction, Middle Cerebral Artery; International Normalized Ratio; Male; Middle Aged; Partial Thromboplastin Time; Perfusion Imaging; Thrombin Time; Thrombolytic Therapy; Tissue Plasminogen Activator; Tomography, X-Ray Computed; Treatment Outcome

2012
chemdatabank.com